Hims & Hers with 125,000 mental health subscribers for the first time - MedMatch to enable personalized treatment using AI!
Reading Time: 3 minutes
With Hims & Hers (HIMS), another growth stock could start a rebound attempt today after better-than-expected figures and a forecast increase. The telemedicine provider operates a health and wellness platform and focuses on a low-cost alternative to health insurance and visits to the doctor with subscription offers. Over 14,000 daily visits are already processed via this platform. It provides round-the-clock care with specialized doctors on sensitive topics such as men's and women's sexual health, mental health and dermatology. Young target groups...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
